# A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

> **NCT00917306** · PHASE3 · COMPLETED · sponsor: **Peplin** · enrollment: 102 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** PEP005 Gel

## Key facts

- **NCT ID:** NCT00917306
- **Lead sponsor:** Peplin
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2015-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00917306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00917306, "A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00917306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*